Novo Holdings A/S
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.23B
Q ending 2026-03-31
Prior quarter
$1.29B
Q ending 2025-12-31
Change
-4.2% QoQ · -6.1% YoY
Positions
22
reported holdings
Largest positions
All 22 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Edgewise Therapeutics Inc | EWTX | Shares | $168.5M | 5.3M |
| Brookfield Corp | BN | Shares | $141.5M | 3.5M |
| Asml Holding N V | Shares | $125.4M | 95K | |
| Mirum Pharmaceuticals Inc | MIRM | Shares | $122.4M | 1.3M |
| Maplight Therapeutics Inc | MPLT | Shares | $74.9M | 3.7M |
| Salesforce Inc | CRM | Shares | $73.4M | 393K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $56.3M | 1.6M |
| Enliven Therapeutics Inc | ELVN | Shares | $50.2M | 1.3M |
| Vaxcyte Inc | PCVX | Shares | $50.0M | 860K |
| Pharvaris N V | Shares | $49.4M | 1.8M | |
| Arrivent Biopharma Inc | AVBP | Shares | $44.8M | 1.9M |
| Viridian Therapeutics Inc | VRDN | Shares | $39.1M | 2.0M |
| Celldex Therapeutics Inc New | CLDX | Shares | $38.1M | 1.2M |
| Apogee Therapeutics Inc | APGE | Shares | $37.9M | 450K |
| Biomarin Pharmaceutical Inc | BMRN | Shares | $37.3M | 660K |
| 4D Molecular Therapeutics In | FDMT | Shares | $34.0M | 3.7M |
| Alibaba Group Hldg Ltd | BABA | Shares | $32.3M | 257K |
| Xenon Pharmaceuticals Inc | XENE | Shares | $28.2M | 485K |
| Bridgebio Oncology Therapeut | BBOT | Shares | $19.6M | 2.2M |
| Valneva Se | VALN | Shares | $6.6M | 1.1M |
| Lanzatech Global Inc | LNZA | Shares | $2.5M | 158K |
| Marqeta Inc | Shares | $1.8M | 442K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.